Accuray to Participate at 37th Annual Roth Conference
Accuray (NASDAQ: ARAY) has announced its participation in the 37th Annual Roth Conference scheduled for March 16-18, 2025, in Dana Point, California. The company's management will engage in a fireside chat on March 18, 2025, at 9:30am PT / 12:30pm ET, and will be available for one-on-one investor meetings.
A live webcast of the fireside chat will be accessible through their website at investors.accuray.com, with replay available for 90 days after the presentation. Accuray, headquartered in Madison, Wisconsin, specializes in radiation therapy solutions for oncology and neuro-radiosurgery, focusing on developing innovative treatments for complex cases while simplifying common procedures.
Accuray (NASDAQ: ARAY) ha annunciato la sua partecipazione alla 37ª Conferenza Annuale Roth in programma dal 16 al 18 marzo 2025 a Dana Point, California. La direzione dell'azienda parteciperà a una chiacchierata informale il 18 marzo 2025, alle 9:30 PT / 12:30 ET, e sarà disponibile per incontri individuali con gli investitori.
Una diretta streaming della chiacchierata sarà accessibile tramite il loro sito web all'indirizzo investors.accuray.com, con replay disponibile per 90 giorni dopo la presentazione. Accuray, con sede a Madison, Wisconsin, si specializza in soluzioni di terapia radiante per oncologia e neurochirurgia radiochirurgica, concentrandosi sullo sviluppo di trattamenti innovativi per casi complessi, semplificando al contempo le procedure comuni.
Accuray (NASDAQ: ARAY) ha anunciado su participación en la 37ª Conferencia Anual Roth programada para el 16 al 18 de marzo de 2025 en Dana Point, California. La dirección de la empresa participará en una charla informal el 18 de marzo de 2025, a las 9:30 a.m. PT / 12:30 p.m. ET, y estará disponible para reuniones individuales con inversores.
Una transmisión en vivo de la charla estará disponible a través de su sitio web en investors.accuray.com, con una repetición disponible durante 90 días después de la presentación. Accuray, con sede en Madison, Wisconsin, se especializa en soluciones de terapia de radiación para oncología y neurocirugía radioquirúrgica, enfocándose en desarrollar tratamientos innovadores para casos complejos mientras simplifica procedimientos comunes.
Accuray (NASDAQ: ARAY)는 2025년 3월 16일부터 18일까지 캘리포니아 다나 포인트에서 열리는 제37회 연례 로스 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 3월 18일 오전 9시 30분 PT / 오후 12시 30분 ET에 파이어사이드 채팅에 참여하며, 투자자와의 일대일 회의도 진행할 예정입니다.
파이어사이드 채팅의 생중계는 investors.accuray.com 웹사이트를 통해 접속할 수 있으며, 발표 후 90일 동안 다시 볼 수 있습니다. Accuray는 위스콘신주 매디슨에 본사를 두고 있으며, 종양학 및 신경 방사선 수술을 위한 방사선 치료 솔루션을 전문으로 하며, 복잡한 사례에 대한 혁신적인 치료법을 개발하는 동시에 일반적인 절차를 간소화하는 데 집중하고 있습니다.
Accuray (NASDAQ: ARAY) a annoncé sa participation à la 37e Conférence Annuelle Roth prévue du 16 au 18 mars 2025 à Dana Point, Californie. La direction de l'entreprise participera à une discussion informelle le 18 mars 2025 à 9h30 PT / 12h30 ET, et sera disponible pour des réunions individuelles avec des investisseurs.
Une diffusion en direct de la discussion sera accessible via leur site internet à l'adresse investors.accuray.com, avec un replay disponible pendant 90 jours après la présentation. Accuray, dont le siège est à Madison, Wisconsin, se spécialise dans les solutions de thérapie par radiation pour l'oncologie et la radiochirurgie neurochirurgicale, en se concentrant sur le développement de traitements innovants pour des cas complexes tout en simplifiant les procédures courantes.
Accuray (NASDAQ: ARAY) hat seine Teilnahme an der 37. jährlichen Roth-Konferenz angekündigt, die vom 16. bis 18. März 2025 in Dana Point, Kalifornien, stattfinden wird. Das Management des Unternehmens wird am 18. März 2025 um 9:30 Uhr PT / 12:30 Uhr ET an einem informellen Gespräch teilnehmen und steht für persönliche Investorenmeetings zur Verfügung.
Ein Live-Stream des informellen Gesprächs wird über ihre Website unter investors.accuray.com zugänglich sein, mit einer Wiederholung, die 90 Tage nach der Präsentation verfügbar ist. Accuray, mit Hauptsitz in Madison, Wisconsin, ist auf Strahlentherapielösungen für Onkologie und neurochirurgische Radiochirurgie spezialisiert und konzentriert sich darauf, innovative Behandlungen für komplexe Fälle zu entwickeln und gleichzeitig gängige Verfahren zu vereinfachen.
- None.
- None.
Management will participate in a fireside chat on Tuesday, March 18, 2025, at 9:30am PT / 12:30pm ET, and will be available for one-on-one meetings with investors.
A live webcast of the fireside chat can be accessed here and on the Accuray website at investors.accuray.com. The webcast replay of the presentation will be available on the company's website about one hour after the conclusion of the live presentation and will be available for 90 days.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in
Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-participate-at-37th-annual-roth-conference-302399494.html
SOURCE Accuray Incorporated
FAQ
When is Accuray (ARAY) presenting at the 37th Annual Roth Conference 2025?
How long will the ARAY Roth Conference webcast replay be available?
Where can investors access Accuray's (ARAY) Roth Conference presentation?
What is Accuray's (ARAY) main business focus according to the announcement?
Will ARAY management be available for individual investor meetings at the Roth Conference?
